347 related articles for article (PubMed ID: 23044318)
1. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
Li JY; Han C; Zheng LL; Guo MZ
Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
[TBL] [Abstract][Full Text] [Related]
2. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
3. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
[TBL] [Abstract][Full Text] [Related]
4. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
Li L; Yang WT; Zheng PS; Liu XF
Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer.
Jia Y; Yang Y; Zhan Q; Brock MV; Zheng X; Yu Y; Herman JG; Guo M
J Mol Diagn; 2012 Nov; 14(6):577-85. PubMed ID: 22921431
[TBL] [Abstract][Full Text] [Related]
6. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
[TBL] [Abstract][Full Text] [Related]
7. SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer.
Yin D; Jia Y; Yu Y; Brock MV; Herman JG; Han C; Su X; Liu Y; Guo M
Discov Med; 2012 Jul; 14(74):33-40. PubMed ID: 22846201
[TBL] [Abstract][Full Text] [Related]
8. Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer.
Zhao H; Li J; Li X; Han C; Zhang Y; Zheng L; Guo M
Curr Protein Pept Sci; 2015; 16(4):316-21. PubMed ID: 25929866
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells.
Gilbert-Sirieix M; Makoukji J; Kimura S; Talbot M; Caillou B; Massaad C; Massaad-Massade L
PLoS One; 2011; 6(7):e22280. PubMed ID: 21814573
[TBL] [Abstract][Full Text] [Related]
10. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
Geng Q; Deng H; Fu J; Cui F
Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
12. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
[TBL] [Abstract][Full Text] [Related]
13. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.
Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M
Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530
[TBL] [Abstract][Full Text] [Related]
14. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
Fan C; Wang W; Jin J; Yu Z; Xin X
Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
[TBL] [Abstract][Full Text] [Related]
15. Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
Cao YM; Gu J; Zhang YS; Wei WJ; Qu N; Wen D; Liao T; Shi RL; Zhang L; Ji QH; Wang Y; Sun GH; Zhao YX; Wang YJ; Yu J; Zhu YX
Oncol Rep; 2018 Jan; 39(1):338-348. PubMed ID: 29115628
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
Zhou Z; Liu Y; Ma M; Chang L
Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
[TBL] [Abstract][Full Text] [Related]
18. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling.
Cho SW; Kim YA; Sun HJ; Ahn HY; Lee EK; Yi KH; Oh BC; Park DJ; Cho BY; Park YJ
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1641-9. PubMed ID: 24848709
[TBL] [Abstract][Full Text] [Related]
20. TRIM30 modulates Interleukin-22-regulated papillary thyroid Cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination.
Li W; Li F; Lei W; Tao Z
Cell Commun Signal; 2019 Dec; 17(1):162. PubMed ID: 31823782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
